Coupa Software, Glaukos rise; Occidental Petroleum falls
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday: EQT Corp., up 57 cents to $46. The natural gas company announced the purchase of gas and pipeline assets and doubled its stock buyback program. Coupa Software Inc., up $10 to $65.82. The software company reported strong second-quarter financial results. HealthEquity Inc., up 64 cents to $64.08. The provider of services for managing health care accounts raised its revenue forecast for the year. Occidental Petroleum Corp., down $1.45 to $65.43. Energy stocks slipped along with falling oil prices. Target Corp., up $7.21 to $170.79. The retailer is dropping the mandatory retirement age for its CEO, allowing Brian Cornell to stay on for three more years. United Parcel Service Inc., up 33 cents to $196.29. The package delivery service plans to hire more than 100,000 extra workers to help handle an increase in packages during the critical holiday season. Glaukos Corp., up $8.91 to $57.01. The drug developer gave investors an encouraging update on a potential glaucoma treatment.
Coupa Software, Glaukos rise; Occidental Petroleum falls
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday: EQT Corp., up 57 cents to $46. The natural gas company announced the purchase of gas and pipeline assets and doubled its stock buyback program. Coupa Software Inc., up $10 to $65.82. The software company reported strong second-quarter financial results. HealthEquity Inc., up 64 cents to $64.08. The provider of services for managing health care accounts raised its revenue forecast for the year. Occidental Petroleum Corp., down $1.45 to $65.43. Energy stocks slipped along with falling oil prices. Target Corp., up $7.21 to $170.79. The retailer is dropping the mandatory retirement age for its CEO, allowing Brian Cornell to stay on for three more years. United Parcel Service Inc., up 33 cents to $196.29. The package delivery service plans to hire more than 100,000 extra workers to help handle an increase in packages during the critical holiday season. Glaukos Corp., up $8.91 to $57.01. The drug developer gave investors an encouraging update on a potential glaucoma treatment.